Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #60,251 to #60,300.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Differentiating dermatomyositis from other diseases (4 revisions)
  2. Differentiating drug-induced lupus erythematosus from other diseases (4 revisions)
  3. Differentiating tonsillits from other diseases (4 revisions)
  4. Diffuse esophageal spasm primary prevention (4 revisions)
  5. Diffuse esophageal spasm screening (4 revisions)
  6. Diffuse large B cell lymphoma electrocardiogram (4 revisions)
  7. Digestive enzyme (4 revisions)
  8. Dihydralazine (4 revisions)
  9. Dihydrostreptomycin (4 revisions)
  10. Diiodohydroxyquinoline (4 revisions)
  11. Diiodotyrosine (4 revisions)
  12. Dilated cardiomyopathy genetic testing (4 revisions)
  13. Diphtheria case study one (4 revisions)
  14. Diphyllobothriasis Surgery (4 revisions)
  15. Diphyllobothriasis surgery (4 revisions)
  16. Dirlotapide (4 revisions)
  17. Bile duct cyst overview (4 revisions)
  18. Bile plug syndrome (4 revisions)
  19. Biliary atresia history and symptoms (4 revisions)
  20. Biliary dyskinesia causes (4 revisions)
  21. Biliary dyskinesia diagnostic criteria (4 revisions)
  22. Biliary dyskinesia epidemiology and demographics (4 revisions)
  23. Biliary dyskinesia laboratory findings (4 revisions)
  24. Biliary dyskinesia pathophysiology (4 revisions)
  25. Biliary dyskinesia physical examination (4 revisions)
  26. Biliary fistula (patient information) (4 revisions)
  27. Biliary fistula historical perspective (4 revisions)
  28. Binge eating (4 revisions)
  29. Biochemistry of Alzheimer's disease (4 revisions)
  30. Biomarker (4 revisions)
  31. Biophysics (4 revisions)
  32. Biperiden (4 revisions)
  33. Bipolar disorder MRI (4 revisions)
  34. Bipolar disorder future or investigational therapies (4 revisions)
  35. Bipolar disorder laboratory findings (4 revisions)
  36. Bladder cancer cost-effectiveness of therapy (4 revisions)
  37. Bladder cancer echocardiography or ultrasound (4 revisions)
  38. Bladder cancer future or investigational therapies (4 revisions)
  39. Bladder rupture (4 revisions)
  40. Blastomycosis secondary prevention (4 revisions)
  41. Bleach (4 revisions)
  42. Blind loop syndrome primary prevention (4 revisions)
  43. Blood flow (4 revisions)
  44. Blood urea nitrogen (4 revisions)
  45. Bloom syndrome protein (4 revisions)
  46. Bobtest (4 revisions)
  47. Boceprevir adverse reactions (4 revisions)
  48. Boceprevir warnings and precautions (4 revisions)
  49. Boerhaave syndrome MRI (4 revisions)
  50. Boerhaave syndrome other diagnostic studies (4 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)